GlobeNewswire
ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION
📈
AI Sentiment
Highly Positive
8/10
Oragenics Inc. News
Latest updates and market news for OGEN
2 news
Mar 11 - Mar 17, 2026
Page 1
GlobeNewswire
ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION
📈
AI Sentiment
Highly Positive
8/10
Share this news page